Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a sing... von Stuart, A.S.V, Shaw, R.H, Liu, X, Greenland, M, Aley, P.K, Andrews, N.J, Cameron, J.C, Charlton, S, Clutterbuck, E.A, Collins, A.M, Darton, T, Dinesh, T, Duncan, C.J.A, England, A, Faust, S.N, Ferreira, D.M, Finn, A, Goodman, A.L, Green, C.A, Hallis, B, Heath, P.T, Hill, H, Horsington, B.M, Lambe, T, Lazarus, R, Libri, V, Lillie, P.J, Mujadidi, Y.F, Payne, R, Plested, E.L, Provstgaard-Morys, S, Ramasamy, M.N, Ramsay, M, Read, R.C, Robinson, H, Screaton, G.R, Singh, N, Turner, D.P.J, Turner, P.J, Vichos, I, White, R, Nguyen-Van-Tam, J.S, Snape, M.D

Volltext bestellen